Diane Gesty‐Palmer
BioCryst Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Protein Kinase Regulation and GTPase Signaling, Neuropeptides and Animal Physiology, Diabetes Treatment and Management, Diabetes Management and Research
Most-Cited Works
- → Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation(2006)461 cited
- → Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes(2017)406 cited
- → Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling(2010)359 cited
- → The Stability of the G Protein-coupled Receptor-β-Arrestin Interaction Determines the Mechanism and Functional Consequence of ERK Activation(2003)353 cited
- → Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors(2008)231 cited
- → A β-Arrestin–Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation(2009)200 cited
- → RecurrentStaphylococcus aureusBacteremia: Pulsed‐Field Gel Electrophoresis Findings in 29 Patients(1999)147 cited
- → The Oxysterol, 27-Hydroxycholesterol, Links Cholesterol Metabolism to Bone Homeostasis Through Its Actions on the Estrogen and Liver X Receptors(2011)127 cited
- → The Endogenous Selective Estrogen Receptor Modulator 27-Hydroxycholesterol Is a Negative Regulator of Bone Homeostasis(2010)104 cited
- → β-Arrestin- and G Protein Receptor Kinase-Mediated Calcium-Sensing Receptor Desensitization(2005)77 cited